Hanseatic Management Services Inc Pacira Bio Sciences, Inc. Transaction History

Hanseatic Management Services Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$35.53 - $43.38 $283,778 - $346,476	7,987 New	7,987 $610,000
Q2 2022 Aug 05, 2022	SELL	$51.49 - $81.64 $411,250 - $652,058	-7,987 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$60.03 - $76.49 $479,459 - $610,925	7,987 New	7,987 $610,000
Q3 2017 Nov 07, 2017	SELL	$35.7 - $39.5 $535 - $592	-15 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	15	15 $1,000

260

49.5M

1.03M

139K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.19B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.